 |
인쇄하기
취소
|
Yuhan seeking psychoneurotic markets.
Yuhan recently obtained the KFDA approval of Voglicose, an anti-diabetic drug and Sediel tab., an anti-anxiety and depression drug.
The efficacy equivalent test of Voglicose was accepted through a comparative pharmacodynamic test as the first case in Korea, which will be launched into the market around coming Feb. next year.
The bulk of Voglicose is being produced by Yuhan Chemical, a Yuh...
The efficacy equivalent test of Voglicose was accepted through a comparative pharmacodynamic test as the first case in Korea, which will be launched into the market around coming Feb. next year.
The bulk of Voglicose is being produced by Yuhan Chemical, a Yuh...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.